IPS-01002

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameIPS-01002
Drug Alias NameEGFR kinase inhibitor (InnoPharmaScreen)IPS-01002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnoPharmaScreen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoPharmaScreen Inc
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A